Badanie IREC

NON-COMMERCIAL, RANDOMIZED, MULTICENTER, PROSPECTIVE, INTERVENTIONAL CLINICAL TRIAL

IREC Study

Impact of irreversible electroporation with calcium chloride, electrochemotherapy and electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression-free survival in patients with pancreatic cancer (IREC)

Dear Sir/Madam,

We invite you to participate in a phase III interventional clinical trial, acronym IREC, aimed at developing a new form of pancreatic cancer treatment based on irreversible electroporation, calcium electroporation, and electrochemotherapy.

The study will assess the impact of the therapy on the quality of life and progression-free survival of patients.

zIf you need assistance,
please contact:

BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: 666-069-834
email: [email protected]

Sponsor
Uniwersytet Medyczny
im. Piastów Śląskich we Wrocławiu
wyb. Ludwika Pasteura 1,
50-367 Wrocław
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu Agencja Badań Medycznych Uniwersyteckie Centrum Wsparcia Badań Klinicznych we Wrocławiu